Menu
Healthcare is undergoing major transformations that will last years, and one of the best ways to play this transformation is with innovative biotech stocks. More
Boston Scientific Corporation stock is up today following news of a settled lawsuit with Johnson & Johnson over its purchase of Guidant. More
Options data is telling investors to take a closer look at Johnson & Johnson (JNJ), Orbitz Worldwide, Inc. (OWW) and Alibaba Group Holding Ltd (BABA). More
A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (NYSE:JNJ) is the #14 broker pick. More
Johnson & Johnson released Q4 earnings that disappointed some investors. When digging deeper, JNJ stock seems to show promise. More
Healthcare stocks finished up 0.7% on Wall Street today. More
Based on the most recent short interest data from Nasdaq, Johnson & Johnson (NYSE:JNJ) has taken over the position of #11 most shorted Dow component, from UnitedHealth Group Inc. (NYSE:UNH) More
